Transplantation and Cellular Therapy | 2024
Axicabtagene ciloleucel versus tisagenlecleucel for relapsed or refractory large B cell lymphoma: A systematic review and meta-analysis.
Gagelmann N, Bishop M, Ayuk F, Bethge W, Glass B, Sureda A, Pasquini MC, Kröger N
PubMed
PMID: 38281590
Abstract
Related Articles
CIBMTR Study #: CIBMTR_NA